← Back to Search

Antiplatelet Agent

Clopidogrel for Coronary Artery Disease (ISAR-SAFE Trial)

Phase 4
Waitlist Available
Led By Jurriёn M ten Berg, MD
Research Sponsored by Deutsches Herzzentrum Muenchen
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 months after randomization
Awards & highlights

ISAR-SAFE Trial Summary

The purpose of this study is to determine whether a 6 month duration of clopidogrel therapy after DES implantation is not inferior to that of a 12 month therapy.

ISAR-SAFE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 months after randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months after randomization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Composite of death, myocardial infarction, stent thrombosis, stroke or TIMI major bleeding.
Secondary outcome measures
The individual components of the primary endpoint

ISAR-SAFE Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: ClopidogrelActive Control1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Deutsches Herzzentrum MuenchenLead Sponsor
117 Previous Clinical Trials
83,701 Total Patients Enrolled
27 Trials studying Coronary Artery Disease
29,305 Patients Enrolled for Coronary Artery Disease
Adnan Kastrati, MDStudy ChairDeutsches Herzzentrum Muenchen
32 Previous Clinical Trials
34,069 Total Patients Enrolled
12 Trials studying Coronary Artery Disease
19,230 Patients Enrolled for Coronary Artery Disease
Jurriёn M ten Berg, MDPrincipal InvestigatorSt. Antonius Hospital Nieuwegein, Department of Cardiology

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting
2008. "Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00661206.
All > Uti > Plavix
~242 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top